{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:45:24Z","timestamp":1788432324276,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jaci.2025.02.002","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T11:27:35Z","timestamp":1739446055000},"page":"1481-1482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Is dupilumab use in atopic dermatitis associated with cutaneous T-cell lymphoma?"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6664-463X","authenticated-orcid":false,"given":"Peck Y.","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.02.002_bib1","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jaci.2024.10.028","article-title":"Integrative epidemiology and immunotranscriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy","volume":"155","author":"Cabrera-Perez","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.002_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.hoc.2018.09.001","article-title":"Mycosis fungoides and S\u00e9zary syndrome: an update","volume":"33","author":"Larocca","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaci.2025.02.002_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-021-00296-9","article-title":"Cutaneous T cell lymphoma","volume":"7","author":"Dummer","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaci.2025.02.002_bib4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-2133.2003.05551.x","article-title":"Cutaneous T-cell lymphoma and atopy: is there an association?","volume":"149","author":"Mehrany","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2025.02.002_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clml.2020.11.007","article-title":"Mycosis fungoides and its relationship to atopy, serum total IgE, and eosinophil counts","volume":"21","author":"Vonderheid","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jaci.2025.02.002_bib6","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jamadermatol.2023.3849","article-title":"Dupilumab-associated lymphoid reactions in patients with atopic dermatitis","volume":"159","author":"Boesjes","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2025.02.002_bib7","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s12325-022-02071-y","article-title":"Prescription market share and treatment patterns in atopic dermatitis: a retrospective observational study using US insurance claims","volume":"39","author":"Fenske","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaci.2025.02.002_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaad.2020.03.050","article-title":"Progression of cutaneous T-cell lymphoma after dupilumab: case review of 7 patients","volume":"83","author":"Espinosa","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2025.02.002_bib9","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1111\/jdv.20141","article-title":"Cutaneous T-cell lymphoma and dupilumab use: a retrospective matched cohort study of clinical characteristics and treatment outcomes","volume":"39","author":"Stuver","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2025.02.002_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.12788\/cutis.0066","article-title":"Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumab","volume":"106","author":"Mollanazar","year":"2020","journal-title":"Cutis"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925001617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925001617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:28:57Z","timestamp":1777264137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925001617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0091674925001617"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.02.002","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is dupilumab use in atopic dermatitis associated with cutaneous T-cell lymphoma?","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.10.028","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}